Composition
- Active ingredients
- LAMIVUDINE 300MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LAMIVUDINE 150MG · TabletANDA203586-001 · Discontinued
- LAMIVUDINE 150MG · TabletANDA077221-001 · Prescription
- LAMIVUDINE 300MG · TabletANDA077221-002 · Prescription
- LAMIVUDINE 300MG · TabletANDA090198-002 · Prescription
- LAMIVUDINE 150MG · TabletANDA090198-001 · Prescription
- LAMIVUDINE 300MG · TabletANDA202032-002 · Discontinued
- LAMIVUDINE 150MG · TabletANDA202032-001 · Discontinued
- LAMIVUDINE 10MG/ML · SolutionANDA203564-001 · Prescription
- LAMIVUDINE 300MG · TabletANDA078850-002 · Tentative approval
- LAMIVUDINE 150MG · TabletANDA078850-001 · Tentative approval
- LAMIVUDINE 300MG · TabletANDA206974-002 · Prescription
- LAMIVUDINE 150MG · TabletANDA206974-001 · Prescription
- LAMIVUDINE 10MG/ML · SolutionANDA077980-001 · Tentative approval
- LAMIVUDINE 100MG · Tablet
At a glance
- Brand name
- Lamivudine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Teva Pharms
- Status
- Tentative approval
- FDA approval
- 22 Mar 2011
- Application
- ANDA078636-002